Customer Support  |  Log In  |  IPA Free Trial

Investors

Institutional Investors

The company is financed by premier technology and life sciences investors, including:

Accel Partners
Questmark Partners
Three Arch Partners
Industry Ventures
Rho Ventures

In addition, the company has received strategic investments from Oracle, Affymetrix, and Millennium Pharmaceuticals.


Select Individual Investors

Stephen Fodor, Ph.D. - Chairman and CEO, Affymetrix, Inc.
Edward Penhoet, Ph.D. - Retired Co-Founder, President and CEO, Chiron Corporation
George Poste, Ph.D. - Director, Arizona Biodesign Institute
Lubert Stryer, Ph.D. - Professor of Neurobiology, Stanford University
John A. Young - Retired CEO, Hewlett Packard
Alejandro Zaffaroni, Ph.D. - Director Emeritus and Co-Founder, Alza Corporation